Bacterial contamination of platelet concentrates: incidence, significance, and prevention

M A Blajchman1, M Goldman

  • 1Department of Pathology and Medicine, McMaster University, and Canadian Blood Services, Hamilton, Ontario, Canada.

Seminars in Hematology
|December 1, 2001
PubMed

Insights

Bacterial contamination in blood transfusions, especially platelets, can cause severe sepsis. While overall contamination is 1 in 3,000, severe septic episodes are estimated at 1 in 50,000 platelet units, prompting new preventative measures.

Area of Science:

  • Transfusion Medicine
  • Microbiology
  • Public Health

Background:

  • Bacterial contamination is a long-standing complication of allogeneic blood transfusions.
  • It remains the leading microbiological cause of transfusion-associated morbidity and mortality.
  • Platelet concentrates are more frequently implicated in transfusion-associated sepsis than red blood cells.

Purpose of the Study:

  • To review the incidence and impact of bacterial contamination in blood products.
  • To highlight the risks associated with transfusion-transmitted sepsis, particularly from platelet concentrates.
  • To discuss current and proposed strategies for preventing and mitigating this transfusion risk.

Main Methods:

  • Review of historical data and current literature on bacterial contamination in blood products.
  • Analysis of incidence rates for contaminated cellular blood products and transfusion-associated sepsis.
  • Examination of factors influencing morbidity and mortality, including bacterial load and endotoxins.

Main Results:

  • The incidence of contaminated cellular blood products is approximately 1 in 3,000.
  • Severe septic episodes are estimated to occur in about 1 in 50,000 platelet units transfused.
  • While many contaminated units have low organism counts, some contain virulent bacteria and endotoxins, leading to severe patient outcomes.

Conclusions:

  • Bacterial contamination of blood products, particularly platelets, poses a significant risk of transfusion-associated sepsis.
  • The incidence of severe septic episodes necessitates ongoing vigilance and the implementation of preventative measures.
  • Heightened awareness has led to the development and application of strategies to control this transfusion-associated risk.